查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434576

3D 生物列印市場：按組件、技術和最終用戶分類 - 2024-2030 年全球預測

3D Bioprinting Market by Component (3D Bioprinters, Bioinks), Technology (Extrusion-based Bioprinting, Inkjet-based Bioprinting, Laser-assisted Bioprinting), End-user - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年3D生物列印市場規模為17.9億美元，預計2024年將達21.4億美元，2030年將達到63.9億美元，複合年成長率為19.89%。

3D生物列印的全球市場

主要市場統計
基準年[2023] 17.9億美元
預測年份 [2024] 21.4億美元
預測年份 [2030] 63.9億美元
複合年成長率（%） 19.89%
3D生物列印市場-IMG1

3D 生物列印是一項創新技術，將生物墨水與活細胞融合以創建 3D 組織樣結構。該過程在3D空間中逐層列印生物墨水和細胞的混合物。近年來，對3D生物列印技術的需求顯著成長，並已成為各種生物醫學應用的重要工具。疾病建模和組織工程是這項創新技術產生重大影響的兩個重要領域。慢性病在全球的流行以及對有效治療方法日益成長的需求促使研究人員探索 3D 生物列印徹底改變醫療保健的潛力。此外，對個人化醫療應用的需求不斷成長，需要根據個別患者的需求量身定製配方和治療方法，其中 3D 生物列印在實現基於患者遺傳特徵和疾病特徵的客製化方面發揮關鍵作用。可擴展性是 3D 生物列印的關鍵問題。創造更大、更複雜的組織和器官需要提高列印過程的速度和精確度。然而，近年來，專注於開發用於 3D 生物列印應用的新型生醫材料的研究顯著增加。由天然和合成聚合物製成的新型生物墨水專為 3D 生物列印製程而設計。與傳統材料相比，這些生物材料具有多種優勢，包括提高的生物相容性、可調節的機械性能和改善的細胞黏合性能，這些性能對於組織再生至關重要。

區域洞察

美洲 3D生物製程市場仍然處於領先地位，這主要是由技術進步、成熟的製藥工業和堅實的研究基礎設施所推動的。美國在美國地區佔有重要地位，擁有大量聯邦資金來支持 3D 生物列印研究和開發計劃。此外，北美的一些學術機構還建立了專用3D生物列印的研究設施。歐洲正在經歷慢性病的增加和人口老化，迫切需要更有效的藥物和個人化治療，這推動了 3D 生物列印等生物技術的進步。在歐洲，德國、英國、法國和瑞典等國家正成為製藥領域採用3D生物列印技術的重要參與者。近年來，亞洲已成為器官移植中心，隨著該地區人口成長、預期壽命延長、慢性病和需要器官移植的疾病數量相應增加，3D生物列印技術的進步正在迅速加速。此外，亞洲國家之間在醫學研究和技術方面區域合作的發展也對這一成長做出了重大貢獻。印度和中國在開發新穎解決方案方面擁有強大的立足點，專門研究 3D 生物列印技術，例如使用積層製造製程的生物人工器官。

FPNV定位矩陣

FPNV定位矩陣對於評估3D生物列印市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可對 3D 生物列印市場中供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-生物3D列印市場的市場規模與預測是多少？

2-在 3D 生物列印市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-3D生物列印市場的技術趨勢和法律規範是什麼？

4-生物3D列印市場主要廠商的市場佔有率是多少？

5-進入3D生物列印市場的適當型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對疾病建模和組織工程的需求不斷成長
      • 藥物和錠劑研究中擴大採用 3D 生物列印
    • 抑制因素
      • 對合適印刷材料的可擴展性和可用性的擔憂
    • 機會
      • 增加為博士學術計劃提供的研究經費
      • 3D 生物列印機和生醫材料的爆炸性進步
    • 任務
      • 進行細胞生物學研究是資本密集的
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第 6 章 3D 生物列印市場：按組成部分

  • 3D生物列印機
  • 生物墨水

第 7 章 3D 生物列印市場：依技術分類

  • 基於擠壓的生物列印
  • 基於噴墨的生物列印
  • 雷射輔助生物列印

第 8 章 3D 生物列印市場：依最終用戶分類

  • 製藥和生物技術公司
  • 調查機構

第9章美洲3D生物列印市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太3D生物列印市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的3D生物列印市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 投資、資金籌措

第13章競爭產品組合

  • 主要公司簡介
    • 3D BioFibR
    • 3D Bioprinting Solutions
    • 3D Systems Corporation
    • 3DBio Therapeutics
    • Advanced Solutions, Inc.
    • Aspect Biosystems Ltd.
    • Avay Biosciences Private Limited
    • Axolotl Biosystems Ltd.
    • BICO Group AB
    • Brinter Inc.
    • Cellbricks GmbH
    • CollPlant Biotechnologies Ltd.
    • Cyfuse Biomedical KK
    • Desktop Metal, Inc.
    • Fluicell AB
    • FluidForm
    • GE HealthCare Technologies Inc.
    • GeSiM
    • Inventia Life Science Pty Ltd.
    • Medprin Regenerative Medical Technologies Co., Ltd.
    • Organovo Holdings Inc.
    • Pandorum Technologies Pvt. Ltd.
    • Precise Bio Inc.
    • Prellis Biologics
    • REGEMAT 3D SL
    • regenHU Ltd.
    • Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd.
    • ROKIT Healthcare Inc.
    • TheWell Bioscience Inc.
    • UpNano
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-43649B5EE3D1

[180 Pages Report] The 3D Bioprinting Market size was estimated at USD 1.79 billion in 2023 and expected to reach USD 2.14 billion in 2024, at a CAGR 19.89% to reach USD 6.39 billion by 2030.

Global 3D Bioprinting Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.79 billion
Estimated Year [2024] USD 2.14 billion
Forecast Year [2030] USD 6.39 billion
CAGR (%) 19.89%
3D Bioprinting Market - IMG1

3D bioprinting is an innovative technology that merges bioinks and living cells to fabricate 3D structures resembling tissues. This process entails printing the bioink and cell mixture layer by layer in a three-dimensional space. In recent years, the demand for 3D bioprinting technologies has experienced significant growth, emerging as a vital tool in various biomedical applications. Disease modeling and tissue engineering are two critical areas where this innovative technology is making a substantial impact. The rising prevalence of chronic diseases globally and an increasing need for effective treatments have spurred researchers to explore the potential of 3D bioprinting in revolutionizing healthcare. Additionally, there has been a rising demand for personalized medicine applications that necessitate patient-specific drug formulations and treatments tailored to individual needs, where 3D bioprinting plays an essential role by allowing for customization based on patients' genetic profiles or disease characteristics. Scalability remains a significant challenge for 3D bioprinting as current technologies are primarily focused on producing smaller tissue constructs. Creating larger and more complex tissues and organs requires advancements in both the speed and precision of printing processes. However, there has been a marked increase in research focused on developing novel biomaterials for 3D bioprinting applications in recent years. New bioinks composed of natural and synthetic polymers are designed specifically for 3D bioprinting processes. These biomaterials offer several advantages over conventional materials, including enhanced biocompatibility, tunable mechanical properties, and improved cell adhesion characteristics which are essentially required for tissue regeneration.

Regional Insights

The Americas 3D bioprocessing market has remained at the forefront, mainly driven by technological advancement, a well-established pharmaceutical industry, and robust research infrastructure. The United States witnessed a significant position in the American region with notable federal funding to support R&D projects in 3D bioprinting. Furthermore, several North American academic institutions have established dedicated 3D bioprinting research facilities. Europe has been witnessing an increasing prevalence of chronic diseases and an expanding geriatric population, creating an urgent need for more effective pharmaceutical drugs and personalized treatments, which has boosted the advancements in biotechnology, such as 3D bioprinting. Across Europe, countries such as Germany, the UK, France, and Sweden have emerged as key players in adopting 3D bioprinting technologies within their pharmaceutical sectors. In recent years, Asia has emerged as a rising hub for organ transplantation, and 3D bioprinting advancements surged majorly due to the region's growing population, its increasing life expectancy, and the subsequent rise in chronic diseases and ailments requiring organ transplants. Furthermore, the development of regional collaboration among Asian countries in medical research and technology has significantly contributed to this growth. India and China have established their strong foothold in developing novel solutions and specializing in 3D bioprinting technologies such as bioartificial organs using additive manufacturing processes.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the 3D Bioprinting Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the 3D Bioprinting Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the 3D Bioprinting Market, highlighting leading vendors and their innovative profiles. These include 3D BioFibR, 3D Bioprinting Solutions, 3D Systems Corporation, 3DBio Therapeutics, Advanced Solutions, Inc., Aspect Biosystems Ltd., Avay Biosciences Private Limited, Axolotl Biosystems Ltd., BICO Group AB, Brinter Inc., Cellbricks GmbH, CollPlant Biotechnologies Ltd., Cyfuse Biomedical K.K., Desktop Metal, Inc., Fluicell AB, FluidForm, GE HealthCare Technologies Inc., GeSiM, Inventia Life Science Pty Ltd., Medprin Regenerative Medical Technologies Co., Ltd., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., Precise Bio Inc., Prellis Biologics, REGEMAT 3D S.L., regenHU Ltd., Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd., ROKIT Healthcare Inc., TheWell Bioscience Inc., and UpNano.

Market Segmentation & Coverage

This research report categorizes the 3D Bioprinting Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • 3D Bioprinters
    • Bioinks
  • Technology
    • Extrusion-based Bioprinting
    • Inkjet-based Bioprinting
    • Laser-assisted Bioprinting
  • End-user
    • Pharmaceutical & Biotechnology Companies
    • Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the 3D Bioprinting Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the 3D Bioprinting Market?

3. What are the technology trends and regulatory frameworks in the 3D Bioprinting Market?

4. What is the market share of the leading vendors in the 3D Bioprinting Market?

5. Which modes and strategic moves are suitable for entering the 3D Bioprinting Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. 3D Bioprinting Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for disease modeling and tissue engineering
      • 5.1.1.2. Increase in deployment of 3D bioprinting across research of drugs and pills
    • 5.1.2. Restraints
      • 5.1.2.1. Concern over scalability and availability of suitable printing materials
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing research funding provided to doctoral academic projects
      • 5.1.3.2. Proliferation in advancements of 3D bioprinters and biomaterials
    • 5.1.4. Challenges
      • 5.1.4.1. Capital intensive to perform cell biology research
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. 3D Bioprinting Market, by Component

  • 6.1. Introduction
  • 6.2. 3D Bioprinters
  • 6.3. Bioinks

7. 3D Bioprinting Market, by Technology

  • 7.1. Introduction
  • 7.2. Extrusion-based Bioprinting
  • 7.3. Inkjet-based Bioprinting
  • 7.4. Laser-assisted Bioprinting

8. 3D Bioprinting Market, by End-user

  • 8.1. Introduction
  • 8.2. Pharmaceutical & Biotechnology Companies
  • 8.3. Research Organizations

9. Americas 3D Bioprinting Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific 3D Bioprinting Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa 3D Bioprinting Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player
    • 12.3.1. Agreement, Collaboration, & Partnership
      • 12.3.1.1. Stratasys enters bioprinting partnership with CollPlant; announces bioprinter based on P3 technology
      • 12.3.1.2. Centre of Excellence for 3D bioprinting inaugurated at IISc Bangalore
    • 12.3.2. Investment & Funding
      • 12.3.2.1. 3D BioFibR Raises Over USD 3.52 Million To Bring 3D Bioprinting Collagen Fiber Products To Market.

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 3D BioFibR
    • 13.1.2. 3D Bioprinting Solutions
    • 13.1.3. 3D Systems Corporation
    • 13.1.4. 3DBio Therapeutics
    • 13.1.5. Advanced Solutions, Inc.
    • 13.1.6. Aspect Biosystems Ltd.
    • 13.1.7. Avay Biosciences Private Limited
    • 13.1.8. Axolotl Biosystems Ltd.
    • 13.1.9. BICO Group AB
    • 13.1.10. Brinter Inc.
    • 13.1.11. Cellbricks GmbH
    • 13.1.12. CollPlant Biotechnologies Ltd.
    • 13.1.13. Cyfuse Biomedical K.K.
    • 13.1.14. Desktop Metal, Inc.
    • 13.1.15. Fluicell AB
    • 13.1.16. FluidForm
    • 13.1.17. GE HealthCare Technologies Inc.
    • 13.1.18. GeSiM
    • 13.1.19. Inventia Life Science Pty Ltd.
    • 13.1.20. Medprin Regenerative Medical Technologies Co., Ltd.
    • 13.1.21. Organovo Holdings Inc.
    • 13.1.22. Pandorum Technologies Pvt. Ltd.
    • 13.1.23. Precise Bio Inc.
    • 13.1.24. Prellis Biologics
    • 13.1.25. REGEMAT 3D S.L.
    • 13.1.26. regenHU Ltd.
    • 13.1.27. Regenovo Biotechnology Co., Ltd. by Shining 3D Tech Co., Ltd.
    • 13.1.28. ROKIT Healthcare Inc.
    • 13.1.29. TheWell Bioscience Inc.
    • 13.1.30. UpNano
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. 3D BIOPRINTING MARKET RESEARCH PROCESS
  • FIGURE 2. 3D BIOPRINTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. 3D BIOPRINTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. 3D BIOPRINTING MARKET DYNAMICS
  • FIGURE 7. 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. 3D BIOPRINTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. 3D BIOPRINTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. 3D BIOPRINTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 6. 3D BIOPRINTING MARKET SIZE, BY 3D BIOPRINTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. 3D BIOPRINTING MARKET SIZE, BY BIOINKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 9. 3D BIOPRINTING MARKET SIZE, BY EXTRUSION-BASED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. 3D BIOPRINTING MARKET SIZE, BY INKJET-BASED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. 3D BIOPRINTING MARKET SIZE, BY LASER-ASSISTED BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. 3D BIOPRINTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. 3D BIOPRINTING MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES 3D BIOPRINTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM 3D BIOPRINTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. 3D BIOPRINTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 143. 3D BIOPRINTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. 3D BIOPRINTING MARKET LICENSE & PRICING